11/12/2024
10:46 AM | BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
11/07/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:12 PM | Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G/A | |
11/05/2024
2:32 PM | Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G | |
11/04/2024
10:20 AM | JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
08/22/2024
3:05 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
|
08/19/2024
4:12 PM | Phathom Pharmaceuticals (Filer)
| Form 424B5 | |
08/19/2024
4:13 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
5:05 AM | Phathom Pharmaceuticals (Subject)
| Form FWP | |
08/08/2024
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
1:52 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
1:50 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
1:51 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
12:59 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
05/31/2024
5:37 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
5:34 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:33 PM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:43 PM | FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:44 PM | COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:46 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:47 PM | Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:14 PM | Phathom Pharmaceuticals (Issuer)
Socks David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:18 PM | Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:03 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:30 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
5:10 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
04/01/2024
5:15 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
03/26/2024
3:05 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
3:00 PM | Phathom Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/26/2024
3:00 PM | Medicxi Growth I LP (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
5:13 AM | Phathom Pharmaceuticals (Issuer)
TAKEDA PHARMACEUTICAL CO LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
5:11 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
01/22/2024
7:19 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
7:21 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
7:22 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
There is a little known company that is changing warfare (Ad) With geo - political instability around the world investors are flocking to defense contract stocks.
There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t |
12/14/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
3:40 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2023
11:15 PM | Phathom Pharmaceuticals (Filer)
| Form EFFECT | |
